Curdlan sulfate (CRDS) in a 21-day intravenous tolerance study in human immunodeficiency virus (HIV) and cytomegalovirus (CMV) infected patients: indication of anti-CMV activity with low toxicity.
Year: 1997
Type: article
Source: PubMed
Authors: M Gordon, S Deeks, C De Marzo, J Goodgame, M Guralnik, W Lang, T Mimura, D Pearce, Y Kaneko
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4684676